foscarnet has been researched along with Infections, Roseolovirus in 35 studies
Foscarnet: An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV.
phosphonoformic acid : Phosphoric acid in which one of the hydroxy groups is replaced by a carboxylic acid group. It is used as the trisodium salt as an antiviral agent in the treatment of cytomegalovirus retinitis (CMV retinitis, an inflamation of the retina that can lead to blindness) and as an alternative to ganciclovir for AIDS patients who require concurrent antiretroviral therapy but are unable to tolerate ganciclovir due to haematological toxicity.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We describe a patient who had severe encephalomyelitis, hypoglycorrhachia, and human herpesvirus 6 identified in his cerebrospinal fluid and serum and who recovered after treatment with foscarnet and ganciclovir." | 7.74 | Severe encephalomyelitis in an immunocompetent adult with chromosomally integrated human herpesvirus 6 and clinical response to treatment with foscarnet plus ganciclovir. ( Bhangoo, MS; Blackburn, BG; Caulfield, AK; Montoya, JG; Troy, SB; Yeom, K, 2008) |
| " We describe a patient who had severe encephalomyelitis, hypoglycorrhachia, and human herpesvirus 6 identified in his cerebrospinal fluid and serum and who recovered after treatment with foscarnet and ganciclovir." | 3.74 | Severe encephalomyelitis in an immunocompetent adult with chromosomally integrated human herpesvirus 6 and clinical response to treatment with foscarnet plus ganciclovir. ( Bhangoo, MS; Blackburn, BG; Caulfield, AK; Montoya, JG; Troy, SB; Yeom, K, 2008) |
| " Although prompt treatment with foscarnet stabilized encephalitis and there were no serious neurological sequelae, the patient developed both hyponatremia and natriuresis 11 days after intravenous administration of foscarnet." | 3.74 | [Salt-wasting nephropathy induced by foscarnet treatment for HHV-6 encephalitis in a hematopoietic stem cell transplant]. ( Akiyama, H; Ando, M; Koshida, A; Najima, Y; Ohashi, K; Sakamaki, H; Yamashita, T, 2008) |
| " Grade 3 or greater adverse events occurred in 9 of the 10 prophylactic PFA patients and in 7 of the 10 control patients who had clinical backgrounds similar to the study subjects and underwent SCT during the same period." | 2.77 | Safety of pre-engraftment prophylactic foscarnet administration after allogeneic stem cell transplantation. ( Hosokawa, K; Ishiyama, K; Katagiri, T; Kondo, Y; Nakao, S; Ohata, K; Takami, A; Yamazaki, H, 2012) |
| "Foscarnet is an effective treatment in HHV-7 associated myelitis." | 2.53 | Acute myelitis by human herpes virus 7 in an HIV-infected patient. ( Buisán Catevilla, J; Corral, I; Escobar-Villalba, A; Galán, JC; Martínez Ulloa, PL; Monreal Laguillo, E; Pérez Torre, P; Rodríguez-Domínguez, M; Sainz de la Maza, S, 2016) |
| "Foscarnet was restarted and continued until day +269 UCBT due to multiple HHV-6 recurrences with persistent hyponatremia." | 1.91 | Human herpesvirus 6 (HHV-6) associated permanent hyponatremia in umbilical cord blood transplant recipient. ( Gannamani, V; Nathan, S; Ustun, C; Varma, A, 2023) |
| "Treatment with foscarnet was effective in achieving improvement of symptoms and clearance of HHV-7 DNA in CSF in the cases of encephalitis and myelitis, while ganciclovir was ineffective in the case of encephalitis." | 1.48 | Molecular detection of human herpesvirus 7 DNA in cerebrospinal fluid from adult patients with neurological disorders. ( Corral, Í; Galán, JC; Kawiorski, MM; López-Martínez, MJ; Rodríguez, M; Sainz de la Maza, S, 2018) |
| "Treatment with foscarnet sodium and hypertonic saline was started with improvement of neurological condition within several days." | 1.39 | Severe hyponatremia caused by syndrome of inappropriate secretion of antidiuretic hormone developed as initial manifestation of human herpesvirus-6-associated acute limbic encephalitis after unrelated bone marrow transplantation. ( Abe, D; Iseki, T; Kawaguchi, T; Kawajiri, C; Nagao, Y; Nakaseko, C; Ohwada, C; Sakai, S; Sakaida, E; Shimizu, N; Sugita, Y; Takeda, Y; Takeuchi, M; Tsukamoto, S; Yamazaki, A; Yokote, K, 2013) |
| "Skin rash are common in immunocompromised patients, particularly after bone marrow transplantation." | 1.38 | Human Herpesvirus-6 cytopathic inclusions: an exceptional and recognizable finding on skin biopsy during HHV6 reactivation after autologous stem-cell transplantation. ( Battistella, M; Bouaziz, JD; Deau, B; Fornecker, L; Houhou, N; Janin, A; Legoff, J; Roux, J; Thieblemont, C, 2012) |
| "A 19-year-old man with Philadelphia chromosome-positive acute lymphoblastic leukemia received an allogeneic hematopoietic cell transplant with unrelated bone marrow." | 1.38 | Prolonged sinus tachycardia caused by human herpesvirus 6 (HHV6) encephalomyelitis after allogeneic bone marrow transplantation. ( Aimoto, M; Bingo, M; Hagihara, K; Hayashi, Y; Hino, M; Hirose, A; Inaba, A; Koh, H; Nakamae, H; Nakamae, M; Nakane, T; Nakao, Y; Nanno, S; Nishimoto, M; Okamura, H; Terada, Y; Yoshida, M; Yoshimura, T, 2012) |
| "Foscarnet treatment resulted both in viral load decline and disappearance of HHV-6-related bone marrow suppression and predisposition to severe infections." | 1.36 | Human herpesvirus 6-related pure red cell aplasia, secondary graft failure, and clinical severe immune suppression after allogeneic hematopoietic cell transplantation successfully treated with foscarnet. ( Dimitroulia, E; Lagadinou, ED; Liga, M; Marangos, M; Panos, G; Spyridonidis, A; Tiniakou, M; Tsakris, A; Tzouvara, E; Zoumbos, N, 2010) |
| "A 10-year-old girl with M2 acute myeloid leukemia underwent an unrelated cord blood transplantation in refractory first relapse." | 1.31 | Herpesvirus-6 encephalitis complicated by Wernicke-Korsakoff syndrome in a pediatric recipient of unrelated cord blood transplantation. ( Cañete, A; Carvajal, E; Castel, V; Fernández, JM; Verdeguer, A, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (34.29) | 29.6817 |
| 2010's | 19 (54.29) | 24.3611 |
| 2020's | 4 (11.43) | 2.80 |
| Authors | Studies |
|---|---|
| Gannamani, V | 1 |
| Varma, A | 1 |
| Nathan, S | 1 |
| Ustun, C | 1 |
| Irie, K | 1 |
| Hiramoto, N | 1 |
| Yamaoka, K | 1 |
| Fuckushima, S | 1 |
| Ito, Y | 1 |
| Toyama, K | 1 |
| Honda, A | 1 |
| Nakazaki, K | 1 |
| Arai, S | 1 |
| Kurokawa, M | 1 |
| Ogata, M | 4 |
| Oshima, K | 1 |
| Ikebe, T | 2 |
| Takano, K | 2 |
| Kanamori, H | 1 |
| Kondo, T | 1 |
| Ueda, Y | 1 |
| Mori, T | 1 |
| Hashimoto, H | 1 |
| Ogawa, H | 1 |
| Eto, T | 1 |
| Ueki, T | 1 |
| Miyamoto, T | 1 |
| Ichinohe, T | 1 |
| Atsuta, Y | 1 |
| Fukuda, T | 2 |
| El-Jawahri, AR | 1 |
| Schaefer, PW | 1 |
| El Khoury, JB | 1 |
| Martinez-Lage, M | 1 |
| Corral, Í | 2 |
| Sainz de la Maza, S | 2 |
| Rodríguez, M | 1 |
| Kawiorski, MM | 1 |
| López-Martínez, MJ | 1 |
| Galán, JC | 2 |
| Zerr, DM | 1 |
| Pantry, SN | 1 |
| Medveczky, MM | 1 |
| Arbuckle, JH | 1 |
| Luka, J | 1 |
| Montoya, JG | 2 |
| Hu, J | 1 |
| Renne, R | 1 |
| Peterson, D | 1 |
| Pritchett, JC | 1 |
| Ablashi, DV | 2 |
| Medveczky, PG | 1 |
| Perissinotti, AJ | 1 |
| Gulbis, A | 1 |
| Shpall, EJ | 1 |
| Howell, J | 1 |
| Mordenti, P | 1 |
| Zaffignani, E | 1 |
| Immovilli, P | 1 |
| Nobili, E | 1 |
| Cavanna, L | 1 |
| Escobar-Villalba, A | 1 |
| Pérez Torre, P | 1 |
| Rodríguez-Domínguez, M | 1 |
| Monreal Laguillo, E | 1 |
| Martínez Ulloa, PL | 1 |
| Buisán Catevilla, J | 1 |
| Agut, H | 2 |
| Bonnafous, P | 1 |
| Gautheret-Dejean, A | 1 |
| Ongrádi, J | 1 |
| Yoshikawa, T | 2 |
| Stercz, B | 1 |
| Troy, SB | 1 |
| Blackburn, BG | 1 |
| Yeom, K | 1 |
| Caulfield, AK | 1 |
| Bhangoo, MS | 1 |
| Lagadinou, ED | 1 |
| Marangos, M | 1 |
| Liga, M | 1 |
| Panos, G | 1 |
| Tzouvara, E | 1 |
| Dimitroulia, E | 1 |
| Tiniakou, M | 1 |
| Tsakris, A | 1 |
| Zoumbos, N | 1 |
| Spyridonidis, A | 1 |
| Ishiyama, K | 2 |
| Katagiri, T | 2 |
| Hoshino, T | 1 |
| Yoshida, T | 1 |
| Yamaguchi, M | 1 |
| Nakao, S | 2 |
| Ohata, K | 1 |
| Hosokawa, K | 1 |
| Kondo, Y | 1 |
| Yamazaki, H | 1 |
| Takami, A | 1 |
| Roux, J | 1 |
| Battistella, M | 1 |
| Fornecker, L | 1 |
| Legoff, J | 1 |
| Deau, B | 1 |
| Houhou, N | 1 |
| Bouaziz, JD | 1 |
| Thieblemont, C | 1 |
| Janin, A | 1 |
| Nishimoto, M | 1 |
| Nakamae, H | 1 |
| Hayashi, Y | 1 |
| Koh, H | 1 |
| Nakane, T | 1 |
| Yoshida, M | 1 |
| Bingo, M | 1 |
| Okamura, H | 1 |
| Aimoto, M | 1 |
| Nanno, S | 1 |
| Yoshimura, T | 1 |
| Inaba, A | 1 |
| Hagihara, K | 1 |
| Nakamae, M | 1 |
| Hirose, A | 1 |
| Nakao, Y | 1 |
| Terada, Y | 1 |
| Hino, M | 1 |
| Satou, T | 1 |
| Inoue, Y | 1 |
| Ando, T | 1 |
| Ikewaki, J | 1 |
| Kohno, K | 1 |
| Nishida, A | 1 |
| Saburi, M | 1 |
| Miyazaki, Y | 1 |
| Ohtsuka, E | 1 |
| Saburi, Y | 1 |
| Kadota, J | 1 |
| Kawaguchi, T | 1 |
| Takeuchi, M | 1 |
| Kawajiri, C | 1 |
| Abe, D | 1 |
| Nagao, Y | 1 |
| Yamazaki, A | 1 |
| Sugita, Y | 1 |
| Tsukamoto, S | 1 |
| Sakai, S | 1 |
| Takeda, Y | 1 |
| Ohwada, C | 1 |
| Sakaida, E | 1 |
| Shimizu, N | 1 |
| Yokote, K | 1 |
| Iseki, T | 1 |
| Nakaseko, C | 1 |
| De Bolle, L | 1 |
| Hatse, S | 1 |
| Verbeken, E | 1 |
| De Clercq, E | 1 |
| Naesens, L | 1 |
| Dewhurst, S | 1 |
| Oberacher-Velten, IM | 1 |
| Jonas, JB | 1 |
| Jünemann, A | 1 |
| Schmidt, B | 1 |
| Moriuchi, M | 1 |
| Moriuchi, H | 1 |
| Akhyani, N | 1 |
| Fotheringham, J | 1 |
| Yao, K | 1 |
| Rashti, F | 1 |
| Jacobson, S | 1 |
| Capouya, JD | 1 |
| Berman, DM | 1 |
| Dumois, JA | 1 |
| Maslin, J | 1 |
| Bigaillon, C | 1 |
| Froussard, F | 1 |
| Enouf, V | 1 |
| Nicand, E | 1 |
| Pöhlmann, C | 1 |
| Schetelig, J | 1 |
| Reuner, U | 1 |
| Bornhäuser, M | 1 |
| Illmer, T | 1 |
| Kiani, A | 1 |
| Ehninger, G | 1 |
| Jacobs, E | 1 |
| Rohayem, J | 1 |
| Chamberlain, MC | 1 |
| Chowdhary, S | 1 |
| Najima, Y | 1 |
| Ohashi, K | 1 |
| Ando, M | 1 |
| Koshida, A | 1 |
| Yamashita, T | 1 |
| Akiyama, H | 1 |
| Sakamaki, H | 1 |
| Carvajal, E | 1 |
| Verdeguer, A | 1 |
| Fernández, JM | 1 |
| Cañete, A | 1 |
| Castel, V | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Assessment of Human Herpes Virus Reactivation 6 Post Autologous Stem Cells , Prospective, Open, Multicenter Study[NCT02090803] | 189 participants (Actual) | Observational | 2012-08-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
9 reviews available for foscarnet and Infections, Roseolovirus
| Article | Year |
|---|---|
[Human herpesvirus-6B encephalitis following allogeneic hematopoietic stem cell transplantation: how should it be managed?]
Topics: Encephalitis, Viral; Foscarnet; Hematopoietic Stem Cell Transplantation; Herpesvirus 6, Human; Human | 2020 |
Human Herpesvirus 6B in the Transplant Recipient: When to Worry, When to Act.
Topics: Antiviral Agents; Encephalitis, Viral; Foscarnet; Ganciclovir; Herpesvirus 6, Human; Humans; Roseolo | 2018 |
Acute myelitis by human herpes virus 7 in an HIV-infected patient.
Topics: Adult; Antiviral Agents; CD4 Lymphocyte Count; Coinfection; DNA, Viral; Foscarnet; Herpesvirus 7, Hu | 2016 |
Human Herpesviruses 6A, 6B, and 7.
Topics: Antiviral Agents; Cidofovir; Cytosine; DNA, Viral; Foscarnet; Ganciclovir; Herpesvirus 6, Human; Her | 2016 |
Roseolovirus-associated encephalitis in immunocompetent and immunocompromised individuals.
Topics: Adult; Antiviral Agents; Child; Cord Blood Stem Cell Transplantation; Cytokines; Encephalitis, Viral | 2017 |
[Human herpesvirus 6 encephalitis].
Topics: Antiviral Agents; Double-Blind Method; Encephalitis, Viral; Foscarnet; Ganciclovir; Herpesvirus 6, H | 2010 |
Deciphering the clinical impact of acute human herpesvirus 6 (HHV-6) infections.
Topics: Antiviral Agents; Child; Child, Preschool; Cidofovir; Cytosine; DNA, Viral; Foscarnet; Ganciclovir; | 2011 |
Human herpesvirus type 6 and human herpesvirus type 7 infections of the central nervous system.
Topics: Antiviral Agents; Central Nervous System Viral Diseases; Foscarnet; Ganciclovir; Herpesvirus 6, Huma | 2004 |
[Treatment of HHV-6 and HHV-7 infections].
Topics: Antiviral Agents; Cidofovir; Cytosine; Drug Therapy, Combination; Foscarnet; Ganciclovir; Herpesviru | 2006 |
2 trials available for foscarnet and Infections, Roseolovirus
| Article | Year |
|---|---|
Preemptive therapy of human herpesvirus-6 encephalitis with foscarnet sodium for high-risk patients after hematopoietic SCT.
Topics: Adolescent; Adult; Chemoprevention; DNA, Viral; Encephalitis; Female; Foscarnet; Hematopoietic Stem | 2011 |
Safety of pre-engraftment prophylactic foscarnet administration after allogeneic stem cell transplantation.
Topics: Adolescent; Adult; Antiviral Agents; DNA, Viral; Encephalitis, Viral; Female; Foscarnet; Hematopoiet | 2012 |
24 other studies available for foscarnet and Infections, Roseolovirus
| Article | Year |
|---|---|
Human herpesvirus 6 (HHV-6) associated permanent hyponatremia in umbilical cord blood transplant recipient.
Topics: Cord Blood Stem Cell Transplantation; Female; Foscarnet; Herpesvirus 6, Human; Humans; Hyponatremia; | 2023 |
Cerebrospinal fluid concentration of foscarnet in patients with HHV-6 encephalitis after haematopoietic stem cell transplantation.
Topics: Antiviral Agents; DNA, Viral; Encephalitis, Viral; Foscarnet; Hematopoietic Stem Cell Transplantatio | 2023 |
Posterior reversible encephalopathy syndrome concurrent with human herpesvirus-6B encephalitis after allogeneic hematopoietic stem cell transplantation.
Topics: Antiviral Agents; Encephalitis, Viral; Foscarnet; Hematopoietic Stem Cell Transplantation; Herpesvir | 2020 |
Clinical characteristics and outcome of human herpesvirus-6 encephalitis after allogeneic hematopoietic stem cell transplantation.
Topics: Adolescent; Antiviral Agents; Encephalitis, Viral; Foscarnet; Ganciclovir; Herpesvirus 6, Human; Hum | 2017 |
Case 5-2018: A 63-Year-Old Man with Confusion after Stem-Cell Transplantation.
Topics: Antiviral Agents; Autopsy; Confusion; Diagnosis, Differential; Fatal Outcome; Foscarnet; Graft vs Ho | 2018 |
Molecular detection of human herpesvirus 7 DNA in cerebrospinal fluid from adult patients with neurological disorders.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; DNA, Viral; Encephalitis, Viral; Femal | 2018 |
Persistent human herpesvirus-6 infection in patients with an inherited form of the virus.
Topics: Adult; Antiviral Agents; Cohort Studies; DNA, Viral; Foscarnet; Ganciclovir; Herpesvirus 6, Human; H | 2013 |
Characterizing human herpes virus 6 following hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; Child, Preschool; DNA, Viral; Drug Therapy, Combin | 2015 |
Human herpesvirus 6 encephalitis simulating brain metastases in a patient with advanced small-cell lung cancer.
Topics: Antiviral Agents; Brain Neoplasms; Encephalitis, Viral; Foscarnet; Ganciclovir; Herpesvirus 6, Human | 2013 |
Severe encephalomyelitis in an immunocompetent adult with chromosomally integrated human herpesvirus 6 and clinical response to treatment with foscarnet plus ganciclovir.
Topics: Adult; Antiviral Agents; Cerebrospinal Fluid; Encephalomyelitis; Foscarnet; Ganciclovir; Herpesvirus | 2008 |
Human herpesvirus 6-related pure red cell aplasia, secondary graft failure, and clinical severe immune suppression after allogeneic hematopoietic cell transplantation successfully treated with foscarnet.
Topics: Adult; Antiviral Agents; Foscarnet; Graft Rejection; Hematopoietic Stem Cell Transplantation; Herpes | 2010 |
Human Herpesvirus-6 cytopathic inclusions: an exceptional and recognizable finding on skin biopsy during HHV6 reactivation after autologous stem-cell transplantation.
Topics: Antiviral Agents; Biopsy; Cytopathogenic Effect, Viral; Exanthema; Foscarnet; Hematopoietic Stem Cel | 2012 |
Prolonged sinus tachycardia caused by human herpesvirus 6 (HHV6) encephalomyelitis after allogeneic bone marrow transplantation.
Topics: Antiviral Agents; Bone Marrow Transplantation; Encephalitis, Viral; Foscarnet; Herpesvirus 6, Human; | 2012 |
Foscarnet against human herpesvirus (HHV)-6 reactivation after allo-SCT: breakthrough HHV-6 encephalitis following antiviral prophylaxis.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Cohort Studies; Encephalitis, Viral; Foscarnet; Hematopoi | 2013 |
Severe hyponatremia caused by syndrome of inappropriate secretion of antidiuretic hormone developed as initial manifestation of human herpesvirus-6-associated acute limbic encephalitis after unrelated bone marrow transplantation.
Topics: Antiviral Agents; Bone Marrow Transplantation; Diagnosis, Differential; DNA, Viral; Female; Foscarne | 2013 |
Human herpesvirus 6 infection arrests cord blood mononuclear cells in G(2) phase of the cell cycle.
Topics: Antiviral Agents; Cell Cycle; Cell Division; Cyclin A; Cyclin B; Cyclin-Dependent Kinases; DNA; Feta | 2004 |
Bilateral optic neuropathy and unilateral tonic pupil associated with acute human herpesvirus 6 infection: a case report.
Topics: Adult; Antibodies, Viral; Antiviral Agents; Eye Infections, Viral; Foscarnet; Herpesvirus 6, Human; | 2005 |
Efficacy of antiviral compounds in human herpesvirus-6-infected glial cells.
Topics: Antiviral Agents; Astrocytes; Astrocytoma; Dose-Response Relationship, Drug; Foscarnet; Herpesvirus | 2006 |
Mollaret's meningitis due to human herpesvirus 6 in an adolescent.
Topics: Adolescent; Antiviral Agents; Female; Foscarnet; Herpesvirus 6, Human; Humans; Meningitis, Viral; Po | 2006 |
Acute bilateral uveitis associated with an active human herpesvirus-6 infection.
Topics: Acute Disease; Aged, 80 and over; Antiviral Agents; Aqueous Humor; Cerebrospinal Fluid; DNA, Viral; | 2007 |
Cidofovir and foscarnet for treatment of human herpesvirus 6 encephalitis in a neutropenic stem cell transplant recipient.
Topics: Antiviral Agents; Cidofovir; Cytosine; Drug Therapy, Combination; Encephalitis, Viral; Foscarnet; Gr | 2007 |
Post-transplant acute limbic encephalitis: clinical features and relationship to HHV6.
Topics: Antiviral Agents; Brain; Confusion; Diagnosis, Differential; DNA, Viral; Female; Foscarnet; Ganciclo | 2008 |
[Salt-wasting nephropathy induced by foscarnet treatment for HHV-6 encephalitis in a hematopoietic stem cell transplant].
Topics: Antiviral Agents; Encephalitis, Viral; Female; Foscarnet; Hematopoietic Stem Cell Transplantation; H | 2008 |
Herpesvirus-6 encephalitis complicated by Wernicke-Korsakoff syndrome in a pediatric recipient of unrelated cord blood transplantation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Child; Combined Modality Therapy; | 2001 |